Fred Alger Management’s Kite Pharma, Inc. KITE Stock Holding History

Fred Alger Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-16,000	Closed	-$1.66M	–	571
2017 Q2	$1.66M	Buy	16,000 +9,000	+129%	+$734K	0.01%	300
2017 Q1	$549K	Buy	+7,000	New	+$433K	﹤0.01%	357
2016 Q1	–	Sell	-26,853	Closed	-$1.66M	–	629
2015 Q4	$1.66M	Buy	+26,853	New	+$1.89M	0.01%	345
2015 Q2	–	Sell	-11,950	Closed	-$689K	–	561
2015 Q1	$689K	Buy	+11,950	New	+$801K	﹤0.01%	527

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fred Alger Management's KITE Position: Q3 2017 in Review

Fred Alger Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 16,000 shares — an estimated $1.66M sold.

Fred Alger Management first reported a position in KITE in Q1 2015 and held it in 4 quarters. The position peaked at $1.66M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Fred Alger Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Fred Alger Management sold 16,000 Kite Pharma, Inc. shares in Q3 2017, an estimated $1.66M.
Fred Alger Management first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 4 quarters.
Fred Alger Management's Kite Pharma, Inc. position peaked at $1.66M in Q2 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Fred Alger Management's 13F filing for Q3 2017, filed 14 Nov 2017.